General Biologics, Inc. Company Description
General Biologics is a small startup genetic engineering company. Our initial goals are to use modern tools of molecular biology, protein biochemistry, and synthetic biology to design, build, test, and ultimately sell, rationally designed proteins for therapeutic use. Our founders have decades of experience in academia, small industrial biotech companies, and large pharmaceutical companies. We own rights to proprietary technology for binding therapeutic proteins to the surface of red blood cells, which confers superior properties to the therapeutic proteins. Our current funding is comprised of investments from founders, a portion of an SBIR grant, and a portion of an STTR contract. We are in the process of applying for additional government funding. We currently sublease office and lab space in Cambridge. As of 3/6/2020 we are in the process of applying for our permit to begin recombinant DNA work.